Healthcare Industry News: IPLEX
News Release - March 5, 2009
Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual MeetingElite MPX(TM): Powerful Multi-Wavelength Workstation Combines Vascular Treatment, Hair Removal and Skin Rejuvenation in a Single System
SmartSense(TM) with ThermaGuide(TM): Unique Thermal Sensing Technology Enhances the World's First Intelligent Delivery System for LaserBodyContouring
ThermaView(TM): Thermal Imaging System for Smartlipo MPX(TM) Offers Combination of Enhanced Safety and Control for Optimal Clinical Results
WESTFORD, Mass., March 5 (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, is again advancing the field with the introduction today of a new multi-wavelength workstation for multiple applications and proprietary new energy-delivery innovations for its Smartlipo MPX laser lipolysis workstation.
At the American Academy of Dermatology's 67th Annual Meeting in San Francisco, Cynosure is launching the Elite MPX. Through the company's patented MultiPlex(TM) technology, Elite MPX combines two wavelengths -- 755nm Alexandrite and 1064 nm Nd:YAG -- along with Xenon Pulsed Light (XPL2) technology to create one of the industry's most powerful workstations for vascular treatment, hair removal and skin rejuvenation. In addition, Cynosure is introducing two new intelligent delivery systems for the Smartlipo MPX workstation for laser lipolysis: SmartSense with ThermaGuide and ThermaView, the world's first subcutaneous temperature sensing technology and thermal imaging system for LaserBodyContouring.
Elite MPX: Built-In Zimmer Cooling Technology Ensures High Level of Patient Comfort
Elite MPX incorporates Cynosure's proprietary MultIPLEX technology, which sequentially fires two wavelengths for more effective treatments than single-wavelength systems. A completely new software system runs the graphically enhanced Graphic User Interface, which makes its operation simple and easy. The workstation also features a built-in Zimmer SmartCoolŽ skin cooling system that is exclusive to Cynosure. Rather than requiring a separate SmartCool device, Zimmer technology is integrated into a single compact module, saving precious office space and reducing treatment time. In addition, the Elite MPX includes eight different spot sizes, including an 18mm spot size that results in 44% more treatment area per pulse than standard spot sizes.
"Cynosure's Elite MPX is a powerful and versatile system that enables clinicians to customize treatments for a broad range of skin types and conditions, including sun-damaged skin, pigmented lesions, dyschromia and rosacea," said Emil Tanghetti, M.D., Clinical Professor of Dermatology at the University of California, Davis and Director of The Center for Dermatology and Laser Surgery, Sacramento, California. "As practitioners, we are seeing a growing cultural diversity within our patient base, and I expect the Elite MPX will provide benefits across the spectrum of applications for these patients."
According to InMedica, the worldwide demand for hair removal, pigmented lesion removal and vascular lesion removal is expected to increase from $650 million in 2007 to $750 million by 2010.
Advancing Intelligent Energy Delivery to the Next Level
SmartSense with ThermaGuide and ThermaView expand the intelligent energy delivery capabilities of Smartlipo MPX, the newest generation in Cynosure's award-winning family of workstations for laser lipolysis.
"Our extensive laser lipolysis expertise, clinical development initiatives and physician training programs have identified the value of measuring tissue temperature to consistently achieve a safer and more uniform treatment," said Cynosure President and Chief Executive Officer Michael Davin. "In 2008, we became the first aesthetic laser company to bring intelligent energy delivery to laser lipolysis with the introduction of SmartSense motion sensing technology for Smartlipo. SmartSense with ThermaGuide and ThermaView build on that success. These groundbreaking products combine to create an intelligent delivery suite designed to maximize the value of Smartlipo MPX for aesthetic surgeons and the clinical outcome for patients."
SmartSense with ThermaGuide: Unique Thermal Sensing Technology
SmartSense with ThermaGuide is equipped with a thermal sensing cannula for measuring temperatures in the subcutaneous areas of the body. This technology allows the practitioner to set temperature thresholds to achieve targeted and controlled energy delivery for a safe and optimal clinical endpoint.
"Based on our clinical studies using SmartSense with ThermaGuide, temperature protocols were developed to identify the temperature threshold for safe and consistent outcomes," said Barry DiBernardo, M.D., Medical Director of New Jersey Plastic Surgery & MedNet Technologies, Inc. "SmartSense with ThermaGuide now provides the practitioner the ability to accurately target specific temperatures when thermal energy is delivered, which is a critical element in maintaining high safety levels for patients."
ThermaView: Enhanced Safety and Control for Optimal Clinical Results
The ThermaView thermal camera system measures skin surface temperature and provides a visual map of temperatures within the treatment area in order to provide a homogeneous delivery of thermal energy. This intelligence is integrated into the Smartlipo MPX system. As a result, thermal energy is delivered to a targeted temperature setting, helping to ensure the safe and effective treatment of the superficial layer of the surface area.
"Cynosure continues to enhance its Smartlipo technology with intelligent delivery systems that create a high level of comfort for the practitioner and patient," said John Millard, M.D., a plastic surgeon based in Denver. "With ThermaView, I see at a glance when the recommended skin temperature has been reached, allowing me to achieve a high degree of efficiency and precision."
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.
For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., including statements related to the performance, safety or results achieved with SmartSense with ThermaGuide, ThermaView or Elite MPX, as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including Cynosure's reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K, which is filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.